Depth by design. Empowering decisions in healthcare.
Our mission is to inform better decision-making and enable transformative change across the healthcare industry.
We partner with you to accelerate business performance through strategic insight and guidance, delivered by the industry’s leading advisory experts.
We deliver an enlightening customer experience through the power of our people, deep insights and a thoughtful approach. We offer deep domain knowledge combined with customer-centric solutions.
We are creating something fresh and relevant for the modern healthcare industry: An ecosystem of advisory businesses that offer access to the best expertise, insight, strategy and data capability across the product life cycle.Learn more about our ecosystem.
Our carefully curated consulting ecosystem offers tailored services to your organization and product, wherever you are in your journey. Operating as individual businesses and together, we inform better decision-making that enables transformative change across the healthcare industry.Learn more about our services.
The Ashfield Advisory ecosystem offers employees the best of two worlds: the security of working for a successful business with a leading reputation in the industry, and the fast-paced, agile, and nimble environment of a start-up.Learn more about our career opportunities.
Read our latest insights
From the finest talent in the industry, we offer a diverse range of perspectives and insights to help you reimagine health, create change and improve the healthcare industry. Explore our latest resources, case studies and insights.
Ashfield acquires Research Partnership
Research Partnership, a leading global healthcare market research and insights company has been acquired by Ashfield.
SITC 2021 round-up: does the new generation of C> give us hope for tackling solid tumors?
The SmartAnalyst Oncology Team at Ashfield’s EmerGENE network sums up their key takeaways from the Society for Immunotherapy of Cancer (SITC) 2021 conference.
Value, Pricing and Access Practice: Where are we investing our energy?
The drug development pipeline has evolved from primary care to specialty and now advances deeper into exquisitely targeted therapies for shrinking niches of addressable populations.